Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits -- Ignore unavailable to you. Want to Upgrade?

To: MIKE DUBIS who wrote (803)	8/14/1998 7:43:00 PM
From: AlienTech	Read Replies (1) \| Respond to of 1016

Book value to me would be a price where there is no more point in selling at a loss but enough positives in the future outlook of the company. I am very baised about this company. Mostly negative about the people but positive on the product ideas, being a sick person myself and getting a lot sicker using crap from big pharma who only cares about a buck. Since I dont expect to live much longer I really dont care about money, no that its not nice but I have this thing about giving up a lost cause :) Buying VVUS under 5 is a bargain. if it goes to 6 thats 20%. Not that many companies out there where the posibility of making 20% exists. Of course I am really really hoping leyland dont screw up royally. Which is whats holding me back at this point. I dont think my longer term outlook on what the company can possibally be has changed. Almost any decent company can buy this crap out and make some decent profits on just the information they hold.